Flumazenil partially reverses gamma-hydroxybutyrate (GHB)-induced coma: a case report.

Chen, Shiao-Yu; Chu, Feng-Yuan; Yang, Chih-Yu; Tarng, Der-Cherng

Chen, Shiao-Yu; Chu, Feng-Yuan; Yang, Chih-Yu; Tarng, Der-Cherng.

Afiliação

Chen SY; Division of Clinical Toxicology and Occupational Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chu FY; Division of Clinical Toxicology and Occupational Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Yang CY; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Tarng DC; Division of Clinical Toxicology and Occupational Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Am J Drug Alcohol Abuse ; 48(5): 629-630, 2022 09 03.

Article em En | MEDLINE | ID: mdl-35867479

Assuntos

Oxibato de Sódio; Baclofeno; Coma/induzido quimicamente; Flumazenil/farmacologia; Flumazenil/uso terapêutico; Humanos; Oxibato de Sódio/uso terapêutico

Palavras-chave

GABA receptor; Gamma-hydroxybutyrate; antidote; flumazenil

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxibato de Sódio Limite: Humans Idioma: En Revista: Am J Drug Alcohol Abuse Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google